Neurodegenerative diseases and traumatic brain injury are devastating conditions. The hope in future treatment lies in the hope of coaxing remaining cells in the brain and nervous system to repair and replace injured or damaged cells. Also known as NeuroICE, the Neuroregeneration program at ICE leads programs in a broad range of research topics that aims to push the field faster and closer toward clinical treatments. To this end, NeuroICE researchers study neuroregeneration, neuronal cell death and survival, apoptosis, cell fate specification, embryonic and adult stem cells, synapse formation, axonal and dendritic targeting, neuronal development, gene expression and the molecular biology of Parkinson’s disease, stroke and vision.
Researchers Uncover New Biological Target For Combating Parkinson’s Disease
Researchers have brought new clarity to the picture of what goes awry in the brain during Parkinson’s disease and identified a compound that eases the disease’s symptoms in mice.
Hopkins Researchers Uncover Key to Antidepressant Response
Researchers have identified a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy. Results of their experiments explain how these therapies likely work to relieve depression by stimulating stem cells in the brain to grow and mature.